Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?

Dalla Volta A, Valcamonico F, Zamboni S, Ferrari VD, Grisanti S, Simeone C, Berruti A.

DOI: 10.23736/s0393-2249.20.04021-7
Published: 2020-10-05
Container: Minerva Urol Nefrol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.23736/s0393-2249.20.04021-7,
  title = {Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?},
  author = {Dalla Volta A and  Valcamonico F and  Zamboni S and  Ferrari VD and  Grisanti S and  Simeone C and  Berruti A.},
  year = {2020},
  journal = {Minerva Urol Nefrol},
  doi = {10.23736/s0393-2249.20.04021-7},
  url = {https://doi.org/10.23736/s0393-2249.20.04021-7}
}

RIS

TY  - JOUR
TI  - Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?
AU  - Dalla Volta A
AU  -  Valcamonico F
AU  -  Zamboni S
AU  -  Ferrari VD
AU  -  Grisanti S
AU  -  Simeone C
AU  -  Berruti A.
PY  - 2020
JO  - Minerva Urol Nefrol
DO  - 10.23736/s0393-2249.20.04021-7
UR  - https://doi.org/10.23736/s0393-2249.20.04021-7
ER  -

APA

A, D. V., F, V., S, Z., VD, F., S, G., C, S., & A., B. (2020). Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?. Minerva Urol Nefrol. https://doi.org/10.23736/s0393-2249.20.04021-7

Source records

europe-pmc · retrieved 2026-11-10T18:13:04.280Z